Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis

NCT01446211 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Change of design consideration

Conditions

Wegeners Granulomatosis

Interventions

DRUG: Gusperimus + glucocorticoids
DRUG: cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids

Sponsor

Nordic Pharma SAS